Global Cardiac Imaging Software Market is valued at USD 403.7 Million in 2021 and expected to reach USD 560.5 Million by 2028 with a CAGR of 4.8% over the forecast period.
Global Cardiac Imaging Software Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2021-2028: Increasing prevalence of cardiovascular diseases, rising geriatric population, and growing number of technological advancements are some of the major factors driving the growth of the Global Cardiac Imaging Software Market.
Cardiac disease is one of the leading causes of death in the world and has been on the rise in the last few years. Cardiac imaging software offers upgraded resolution and overall details of heart's working for productive diagnosis. The software can exhibit the auxiliary useful valuable contrast in the heart that can be furthermore examined and considered to see any present and future expected results of heart conditions. This cardiac imaging software is utilized for determination of heart related issues with the assistance of CT scan, MRI, and angiography, radioactive substances, and different types of radiant energy. Cerebrovascular disease, rheumatic heart disease, peripheral arterial disease, congenital heart disease, coronary heart disease, pulmonary embolism, and deep vein thrombosis are a portion of the significant diseases that can be treated through the cardiac imaging software.
The Covid-19 pandemic has shown a negative impact on the growth of the global cardiac imaging software market. The Covid-19 pandemic had a remarkable disturbance in healthcare provision around the world. During the Covid-19 pandemic, there was reduction in the number of cardiac imaging and delayed cardiac surgeries due to lockdown conditions and social distancing measures. The entire focus of medical and healthcare was shifted on Covid vaccine development and in treating of Covid patients.
The global cardiac imaging software market is segmented on the basis of the imaging type, applications, end-user, and region & country level. On the basis of imaging type, the global cardiac imaging software market is segmented into ultrasound imaging, computed tomography, magnetic resonance, x-ray imaging, and combined modalities. By application, the global cardiac imaging software market is segmented into patient monitoring, diagnostic imaging, and image-guided treatment. By end-user, the global cardiac imaging software market is segmented into hospitals & clinics, cardiovascular clinics, ambulatory surgical centers, diagnostics centers, and others.
The regions covered in the global cardiac imaging software market report are North America, Europe, Asia-Pacific, Latin America, and the rest of the World. On the basis of country level, the market of global cardiac imaging software is sub divided into U.S., Mexico, Canada, U.K., France, Germany, China, Italy, India, Japan, South East Asia, Middle East Asia (Saudi Arabia, UAE, Egypt) GCC, Africa, etc.
|Historical data||2018 - 2021|
|Forecast Period||2022 - 2028|
|Market Size in 2021:||USD 403.7 Million|
|Base year considered||2021|
|Forecast Period CAGR %:||
|Market Size Expected in 2028:||USD 560.5 Million|
|Tables, Charts & Figures:||175|
|Cardiac Imaging Software Companies||FUJIFILM Corporation, Siemens, Canon Inc., NeoSoft LLC, Arterys, Pie Medical Imaging, Medis Medical Imaging, Symphony Innovation, LLC, Circle Cardiovascular Imaging Inc, Koninklijke Philips N.V., GE Healthcare, and others.|
|Segments Covered||By Imaging Type, By Application, By End-User|
|Regional Analysis||North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa|
Some major key players for the global cardiac imaging software market report cover prominent player’s like FUJIFILM Corporation, Siemens, Canon Inc., NeoSoft LLC, Arterys, Pie Medical Imaging, Medis Medical Imaging, Symphony Innovation, LLC, Circle Cardiovascular Imaging Inc, Koninklijke Philips N.V., GE Healthcare, and others.
inHeart Won FDA Clearance for 3D Cardiac Modeling Software
On May 24th, 2022; inHeart announced that it got FDA 510(k) clearance for its inHeart Models software suite for cardiac modelling. France-based inHeart planned its inHeart Models software to empower the 3D visualization and investigation of physical structures for pre-procedural preparation and intraprocedural use. FDA clearance considers the development of the organization's business impression in the U.S. to further develop cardiovascular removal methodology like ventricular tachycardia (VT).
Singapore Launched New AI-Driven Research Laboratory in Cardiac Imaging
On March 9th, 2022; The National Heart Center Singapore announced the establishment of a Cardiovascular Systems Imaging and Artificial Intelligence (CVS.AI) research laboratory. It is an AI-powered research laboratory set up in Singapore and Southeast Asia, studying various aspects of heart disease using different imaging methods.
NIH Researchers Developed MRI with Lower Magnetic Field for Cardiac and Lung Imaging
On October 1st, 2019; Researchers at the National Institutes of Health, along with researchers at Siemens, developed a high-efficiency, low-magnetic-field MRI system that greatly improves the image quality of the lungs & other internal structures of the human body. The new system is more compatible with interventional devices that can greatly enhance the image-guided process of diagnosing and treating the disease, making the system more affordable and accessible to medical imaging for patients.
Increasing Prevalence of Cardiovascular Disease, Rising Geriatric Population, and Growing Number of Technological Advancements are Some of the Major Factors Driving the Market Growth
One of the major factors driving the growth of the cardiac imaging software market is the increasing prevalence of the cardiovascular diseases. For example; according to World Health Organization (WHO); in 2019, there are about 17.9 million individuals died from cardiovascular diseases, addressing 32% of every single worldwide death. Of these deaths, 85% were because of stroke and heart attack. The increasing dominance of cardiovascular disease (CVD) increases the need of perfect diagnosis to treat the patients. Cardiac imaging software provides upgraded resolution and overall details of heart's working for productive diagnosis. Hence, increasing dominance of cardiovascular disease increases the need of cardiac imaging software.
In addition, the rising geriatric population is also boosting the growth of the cardiac imaging software market. For example; as per World Health Organization (WHO); in 2019, the quantity of individuals matured 60 years and older was 1 billion. This number will increment to 1.4 billion by 2030 and 2.1 billion by 2050. Maturing can cause changes in the heart and veins. Changes that occur with age might build an individual's gamble person's risk of heart illness. The older populace is especially susceptible to cardiovascular disease. The high prevalence of cardiovascular disease in geriatric populace has been connected to various variables, including expanded oxidative stress, apoptosis, inflammation and generally speaking myocardial deterioration, and degeneration. Hence, demand of cardiac imaging software increases due to the growing geriatric population.
Moreover, the growing number of technological advancements are also supplementing the market growth. For instance; as per the news published on April 7th, 2022; Next-generation AI cardiac imaging platform launched with new, FDA-approved modules. However, the low healthcare expenditure associated with cardiac imaging software may hinder the market growth. In spite of that, enhancing artificial intelligence in cardiovascular imaging may create more opportunities for the further growth of the global cardiac imaging software market.
North America is Expected to Dominate the Global Cardiac Imaging Software Market
North America is expected to dominate the global cardiac imaging software market within the forecast period due to the increasing high occurrence of cardiovascular diseases, rising disposable income, and growing technological advancements in this region. The increasing high occurrence of cardiovascular diseases is driving the growth of the market. For instance; according to the Centers of Disease Control and Prevention (CDC); in 2019, Unites States, coronary illness is the most well-known sort of heart disease, killing 360,900 individuals in the United States.
The Asia Pacific is the fastest-growing region in the global cardiac imaging software market due to the increasing geriatric population, rising prevalence of chronic diseases, and the growing number of hospitals and healthcare services in this region. For instance; according to aging Asia, in 2019, they were 139 million people aged 65 in India. And, according to Institut Montaigne, on November 3rd, 2020; India has a total of 43,486 private hospitals, 1.18 million beds, 59,264 ICUs, and 29,631 ventilators. On the other hand, there are 25,778 public hospitals, 713,986 beds, 35,700 ICUs, and 17,850 ventilators.
By Imaging Type
Cardiac Imaging Software Market Key Players
Middle East and Africa
We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination interested? please email us firstname.lastname@example.orgJOIN US
BrandEssence® Market Research and Consulting Pvt ltd.
Kemp House, 152 - 160 City Road, London EC1V 2NX
© Copyright 2022-23 BrandEssence® Market Research and Consulting Pvt ltd. All Rights Reserved | Designed by BrandEssence®